Seres Therapeutics's total assets for Q4 2025 were $138.19M, a decrease of -3.68% from the previous quarter. MCRB total liabilities were $93.97M for the fiscal quarter, a -5.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.